Cancer Screening Tests
Thank you for shopping our cancer blood tests. More than 1 million people are diagnosed with cancer every year. Early cancer detection through cancer screening or cancer blood test can provide more options for fighting the disease. These blood tests check for specific markers such as CA-125 and the prostate-specific antigen, which can determine diagnosis for ovarian cancer and prostate cancer respectively. Cancer screening blood tests can also tell you your risk factors for this disease, helping you make the right lifestyle choices to prevent it. Order your Cancer blood test online today!
Browse Cancer Screening Tests Subcategories
Choose One Lab: LABCORP (LC) or QUEST (QD) or ALL
Walk-In Lab is contracted with LabCorp (LC) and Quest Diagnostics (QD) for routine lab testing. Please choose LC or QD to complete your order. If you prefer to receive a kit by mail for specimen collection, please see our Home Test Kits. LC and QD tests must be ordered separately.
LabCorp: Online lab testing is prohibited in MA, MD, NY, NJ and RI.
Quest Diagnostics: Online lab testing is prohibited in AZ, NY, NJ and RI.
-
Prostate-specific Antigen (PSA) Serum Test
The Prostate-Specific Antigen (PSA) Serum Test measures PSA levels in the blood to screen for prostate cancer or other benign prostate conditions. -
Cancer Antigen (CA) 125 Serum Test
Cancer antigen 125 (CA-125) is a protein found in ovarian cancer cells. A CA-125 blood test measures the amount of cancer antigen 125 in the bloodstream. The protein is produced by the cells and can be found in the blood. -
Carcinoembryonic Antigen (CEA) Blood Test
This CEA Blood Test measures the protein in the blood called carcinoembryonic antigen (CEA). This protein can be found on some cancer cell types. -
Prostate-specific Antigen (PSA) Free:Total Ratio Blo...
The Prostate-specific Antigen (PSA) Free:Total Ratio Blood Test compares Total PSA (the amount that is bound to blood proteins) to Free PSA (floats unbound in the blood). -
Carbohydrate Antigen (CA) 19-9 Blood Test
The Carbohydrate Antigen (CA) 19-9 Blood Test is used primarily to monitor response to pancreatic cancer therapy and to monitor recurrence, sometimes to help diagnose pancreatic cancer. However, CA 19-9 may also be elevated with the presence of other cancers. -
Cancer Screening Panel, Women
The Cancer Screening Panel for Women consists of 5 tumor markers to help diagnose and monitor cancer, predict its behavior, and check for recurrence after treatment. -
Alpha-Fetoprotein (AFP) Serum Test
The Alpha-Fetoprotein Serum Test helps to screen for and monitor the treatment of liver, testicular, and ovarian cancers. -
Cancer Screening Panel, Men
The Cancer Screening Panel for Men consists of five tumor markers that can help detect and monitor cancer, predict its behavior, and check for recurrence after treatment. -
Cancer Antigen (CA) 15-3 Blood Test
The Cancer Antigen (CA) 15-3 Blood Test monitors invasive breast cancer treatment and detects possible recurrences. -
Prostate-specific Antigen (PSA) Blood Test, Ultrasen...
PSA test intended for use post-surgery or post-medical treatment of prostate cancer. -
Cancer Antigen (CA) 27.29 Blood Test
The Cancer Antigen 27.29 Blood Test monitors patients with metastatic breast cancer. -
Occult Blood, Fecal, Immunoassay Test
The Occult Blood, Fecal, Immunoassay Test detects blood hidden in a stool sample to help screen for colorectal cancer. -
Beta 2 Microglobulin Serum Test
The Beta 2 Microglobulin Serum Test helps evaluate the severity and prognosis of certain cancers and screens for kidney disorders. -
Calcitonin Blood Test
The Calcitonin Blood Test measures the level of hormone calcitonin in the blood -
Chromogranin A Serum Test
A Chromogranin A Serum Test is used to detect neuroendocrine cancers. -
Neuron-specific Enolase (NSE) Blood Test
The NSE Blood Test is used in the monitoring of patients with small cell lung cancer (SCLC). -
Thyroglobulin Antibody and Thyroglobulin Blood Test,...
The Thyroglobulin test is primarily used as a tumor marker to evaluate the effectiveness of treatment for thyroid cancer and to monitor for recurrence. -
Immunofixation (IFE), Serum and Protein Electrophore...
The IFE test is used to identify monoclonal immunoglobulin gammopathies. It may also indicate conditions such as multiple myeloma or Waldenstrom’s macroglobulinemia. -
Immunofixation (IFE) Serum Test
The Immunofixation (IFE) Serum Test identifies monoclonal immunoglobulin gammopathies, which may indicate multiple myeloma or Waldenstrom's macroglobulinemia. -
Protein Electrophoresis Urine Test, 24-Hour
The Protein Electrophoresis Urine Test, 24-Hour, measures the types of protein in a urine sample collected over 24 hours. -
Vascular Endothelial Growth Factor Blood Test
The Vascular Endothelial Growth Factor test measures VEGF concentration levels in the blood to assess tumor progression and monitor response to treatment. -
Prostatic Acid Phosphatase (PAP) Serum Test
A Prostatic Acid Phosphatase (PAP) Serum Test is an adjunct in the evaluation of possible prostatic malignancy and useful in monitoring therapeutic progress. -
Lysozyme Blood Test
The Lysozyme Blood Test monitors disease progression or regression in confirmed tuberculosis, sarcoidosis, or leukemia. -
Methylated Septin 9 Blood Test
The Methylated Septin 9 blood test screens for colorectal cancer. -
Human Epididymis Protein 4 Blood Test
The Human Epididymis Protein 4 Blood Test monitors epithelial ovarian cancer after treatment to detect recurrence or disease progression. -
Interleukin-2 (IL-2) Blood Test
The Interleukin-2 Test measures the Interleukin-2 level in the blood. -
Interleukin 8 (IL8) Blood Test
The interleukin 8 blood test looks for elevated levels of interleukin 8. -
Breast Cancer Blood Test Panel
The Breast Cancer Blood Test Panel helps screen for and monitor invasive breast cancer. -
Women's Health and Breast Profile, Saliva - Doctor's...
This Women's Health and Breast Profile, Saliva, measures hormone levels in the body to detect a hormone imbalance and assesses the risk of developing breast cancer or other hormone-sensitive cancers.